发明名称 |
Use of interleukine 2 for the treatment of leukemias. |
摘要 |
<p>The invention relates to the use of a polypeptide having human interleukin-2 activity for preparing a pharmaceutical composition intended for the treatment of leukaemias. Polypeptide having human IL-2 activity is understood to mean natural human IL-2 or recombinant human IL-2, that is to say obtained by recombinant DNA technology. The leukaemias to which the invention relates comprise chronic myeloid or chronic lymphoid leukaemias and acute lymphoid or non-lymphoblastic leukaemias, for example myeloid leukaemias characterised in a general manner by the proliferation of blast cells.</p> |
申请公布号 |
EP0426521(A1) |
申请公布日期 |
1991.05.08 |
申请号 |
EP19900402900 |
申请日期 |
1990.10.16 |
申请人 |
ROUSSEL-UCLAF |
发明人 |
BRANDELY, MAUD;MARANINCHI, DOMINIQUE |
分类号 |
A61K38/00;A61K31/00;A61K38/20;A61P35/00;A61P35/02;C07K14/55;C12N15/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|